Mital Jhaveri/LinkedIn
Apr 23, 2026, 14:46
Mital Jhaveri: Anticoagulant Approval and Uptake Timeline
Mital Jhaveri, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared a post on LinkedIn:
“When presenting on anticoagulation recently, I was asked a thought-provoking question: why is anticoagulant use increasing?
The answer goes beyond simply ‘more prescriptions.’
It boils down to two main factors: ease of use and a growing need.
Here are a few key reasons:
- Safer, easier medications: Newer anticoagulants are more predictable, require less monitoring, and have fewer interactions.
- Wider clinical use: Anticoagulants are now utilized in various settings, including atrial fibrillation, venous thromboembolism, post-surgical care, and prevention.
- Aging population: An increasing number of patients are developing conditions like atrial fibrillation that necessitate anticoagulation.
- Earlier detection: Improved screening tools and wearable technology are helping to identify at-risk patients sooner.
- Stronger guidelines: Current clinical recommendations advocate for broader and earlier use in suitable patients.
- Greater physician confidence: Long-term data and real-world experience have made prescribing these medications more routine.
In summary, anticoagulants have transitioned from complex, high-maintenance therapies to standard, widely used treatments in modern healthcare.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 20:46Grace Choung: A Novel CFHR5 Copy Number Variant in Postpartum Atypical HUS
-
Jul 23, 2026, 20:10Mohammad Alzoubi: One Month of Dual Antithrombotic Therapy After PCI Was Non-Inferior to 12 Months
-
Jul 23, 2026, 20:08Ahmed Bennis: Calcitriol Replenishment May Mitigate Ischemic Risk in MASLD
-
Jul 23, 2026, 20:06Mitsuaki Sawano: Can Cardiovascular Risk Prediction Models Developed in One Population be Reliably Applied to Another?
-
Jul 23, 2026, 20:05Abdul Muqtadir Abbasi: Hemostasis Isn’t About Memorizing Factor Numbers – It’s About Recognizing Patterns
-
Jul 23, 2026, 19:40Maureen Macharia: How Apixaban Transformed Modern Anticoagulation
-
Jul 23, 2026, 19:30Jordan Agay: Why We Need to Track the Neurological Costs of Anemia
-
Jul 23, 2026, 19:25William Archibald: Key Takeaways on VTE Cost-Effectiveness and Cancer Associated Thrombosis from ISTH 2026
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100